Friday, May 10, 2013 12:03:42 PM
I am long and I would not complain buying at 0.007 but this seems unlikely without any major setback!
Why am I so sure?
The science behind manf and the diagnostics is strong and reproducible. I actually read most of the scientific literature and there is no doubt in my mind about the potential of MANF. The diagnostics will generate revenues soon enough.
They got rid of toxic financing, although they have been diluting since January, but that's part of the game for a micro cap pharma.
Partnership is expected this year and just that will send the pps around 20 cents.
good luck to all with your trades
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM